Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OXYWILD - Automated Oxygen Titration With O2matic During Walking in Patients With Fibrotic Interstitial Lung Diseases (F-ILD): A Randomized Study

NCT06465654 is registered in ClinicalTrials.gov with Janne Hastrup Jensen as lead sponsor.

NCT NCT06465654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06465654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OXYWILD - Automated Oxygen Titration With O2matic During Walking in Patients With Fibrotic Interstitial Lung Diseases (F-ILD): A Randomized Study
Lead sponsor
Janne Hastrup Jensen
Phase
Not applicable
Overall status
Completed
Start date
June 20, 2024
Completion date
September 10, 2025
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis lung, respiratory therapy